TY - JOUR
T1 - Mesenchymal stem cell therapy of acute thermal burns
T2 - A systematic review of the effect on inflammation and wound healing
AU - Rangatchew, Filip
AU - Vester-Glowinski, Peter
AU - Rasmussen, Bo Sonnich
AU - Haastrup, Eva
AU - Munthe-Fog, Lea
AU - Talman, Maj-Lis
AU - Bonde, Christian
AU - Drzewiecki, Krzysztof T
AU - Fischer-Nielsen, Anne
AU - Holmgaard, Rikke
N1 - Copyright © 2020 Elsevier Ltd and ISBI. All rights reserved.
PY - 2021/3
Y1 - 2021/3
N2 - AIM: Mesenchymal stem cell (MSC) therapies are emerging as a promising strategy to promote tissue repair, and may extend their utility to burn care. This comprehensive review of the extant literature, evaluated all in vivo studies, to elucidate the potential protective and therapeutic effect of MSCs in acute thermal skin burns.METHODS: PubMed was systematically searched, according to PRISMA guidelines, and all relevant preclinical and clinical studies were included according to pre-specified eligibility criteria.RESULTS: Forty-two studies were included in a qualitative synthesis, of which three were human and 39 were animal studies. The preclinical studies showed that MSCs can significantly reduce inflammation, burn wound progression and accelerate healing rate of acute burns. The underlying mechanisms are complex and not fully understood but paracrine modulators, such as immunomodulatory, antioxidative and trophic factors, seem to play important roles. Allogeneic MSC therapy has proved feasible in humans, and could allow for prompt treatment of acute burns in a clinical setting.CONCLUSION: MSC therapy show positive results, regarding improved burn wound healing and immunologic response. However, most findings are based on small animal studies. Randomized clinical trials are warranted to investigate the regenerative effects in human burns before translating the findings into clinical practice.
AB - AIM: Mesenchymal stem cell (MSC) therapies are emerging as a promising strategy to promote tissue repair, and may extend their utility to burn care. This comprehensive review of the extant literature, evaluated all in vivo studies, to elucidate the potential protective and therapeutic effect of MSCs in acute thermal skin burns.METHODS: PubMed was systematically searched, according to PRISMA guidelines, and all relevant preclinical and clinical studies were included according to pre-specified eligibility criteria.RESULTS: Forty-two studies were included in a qualitative synthesis, of which three were human and 39 were animal studies. The preclinical studies showed that MSCs can significantly reduce inflammation, burn wound progression and accelerate healing rate of acute burns. The underlying mechanisms are complex and not fully understood but paracrine modulators, such as immunomodulatory, antioxidative and trophic factors, seem to play important roles. Allogeneic MSC therapy has proved feasible in humans, and could allow for prompt treatment of acute burns in a clinical setting.CONCLUSION: MSC therapy show positive results, regarding improved burn wound healing and immunologic response. However, most findings are based on small animal studies. Randomized clinical trials are warranted to investigate the regenerative effects in human burns before translating the findings into clinical practice.
KW - Burn therapy
KW - Burns
KW - Cell therapy
KW - Mesenchymal stem cells
KW - Regenerative medicine
KW - Wound healing
U2 - 10.1016/j.burns.2020.04.012
DO - 10.1016/j.burns.2020.04.012
M3 - Review
C2 - 33218945
SN - 0305-4179
VL - 47
SP - 270
EP - 294
JO - Burns
JF - Burns
IS - 2
ER -